TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
Cytek Biosciences, Inc. (CTKB)
Company Research
Source: GlobeNewswire
FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced its inclusion on TIME’s 2026 list of America’s Growth Leaders. Presented in partnership with global data firm Statista, the inaugural ranking recognizes the top-performing publicly listed companies in the United States that have demonstrated exceptional growth, financial stability, and stock performance over the past five years. According to TIME and Statista, thousands of businesses are founded in the United States each month, but only a select few sustain growth and deliver long-term value. This list honors companies that are standing the test of time – and leading their industries into the future. Cytek’s inclusion underscores its strong financial foundation, sustained business expansion, and continued success in delivering innovative, high-parameter cell analysis solutions to the global research and clinical communities. “At Cytek, our mi
Show less
Read more
Impact Snapshot
Event Time:
CTKB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTKB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTKB alerts
High impacting Cytek Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
CTKB
News
- Cytek Biosciences (NASDAQ:CTKB) was given a new $6.00 price target on by analysts at Morgan Stanley.MarketBeat
- Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth [Seeking Alpha]Seeking Alpha
- Cytek Biosciences (CTKB): Evaluating Valuation After TIME's 2026 Growth Leaders Recognition and Recurring Revenue Momentum [Yahoo! Finance]Yahoo! Finance
- TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026 [Yahoo! Finance]Yahoo! Finance
- Cytek Biosciences (NASDAQ:CTKB) had its price target lowered by analysts at Piper Sandler from $8.00 to $7.50. They now have an "overweight" rating on the stock.MarketBeat
CTKB
Earnings
- 11/5/25 - Beat
CTKB
Sec Filings
- 11/20/25 - Form 4
- 11/20/25 - Form 4
- 11/20/25 - Form 4
- CTKB's page on the SEC website